Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: ADC Therapeutics SA, 2 years.
ADC Therapeutics SA
Director
Pharvaris N.V.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Pharvaris N.V. | Option exercise | +11,969 | $8.05 | $96,350 |
| Sep 23, 2026 | Pharvaris N.V. | Open-market sale | −11,969 | $33.05 | $395,524 |
| Jun 3, 2026 | ADC Therapeutics SA | Shares withheld for tax | −2,596 | $3.08 | $7,996 |
| Jun 1, 2026 | ADC Therapeutics SA | Grant or award | +45,000 | — | — |
| May 21, 2026 | Pharvaris N.V. | Open-market sale | −9,667 | $30.29 | $292,813 |
| Jun 13, 2025 | ADC Therapeutics SA | Shares withheld for tax | −2,584 | $3.58 | $9,251 |
| Jun 3, 2025 | ADC Therapeutics SA | Grant or award | +40,000 | — | — |
| Jun 17, 2024 | ADC Therapeutics SA | Open-market sale | −1,437 | $2.89 | $4,153 |
| Jun 13, 2024 | ADC Therapeutics SA | Grant or award | +40,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.